FDA Clearance Tracker · P190008-S025
IN.PACT AV Paclitaxel-Coated Percutaneous Transluminal Angioplasty (PTA) Balloon
Last checked: Nov 20, 2026Latest source record: Sep 14, 2023 (this decision)Source: openFDAMethods & limitations
Decided
Sep 14, 2023
Approved
Time to decision
28 days
Received Aug 17, 2023. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Normal 180 Day Track No User Fee
Device class
Class III
The decision
- FDA number
- P190008-S025
- Device name
- IN.PACT AV Paclitaxel-Coated Percutaneous Transluminal Angioplasty (PTA) Balloon
- Applicant
- Medtronic Vascular, Inc.
- Applicant location
- Santa Rosa, CA
- Received
- Aug 17, 2023
- Decided
- Sep 14, 2023
- Decision
- Approved
- Supplement type
- Normal 180 Day Track No User Fee
- Reason for supplement
- Postapproval Study Protocol
- Original approval
- P190008
Device type
- Device class
- Class III
- Specialty
- CardiologyInterventional Cardiology
FDA's approval statement
As written in FDA's record.
Approval of the revised protocol for the post-approval study (PAS) protocol.
Source documents
Other decisions for Medtronic Vascular, Inc.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
K202800 · Decided Nov 18, 2020 · 56 days after receipt
Device type: Catheter, Angioplasty, Peripheral, Transluminal (LIT) · Cardiology
7 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.